Company: PACB
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001299130-25-000090
Chunk: 25

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 25
---
 directors with our business and strategic plans, key policies and practices, principal officers and management structure, auditing and compliance processes, and our Code of Business Conduct. In addition, our committees monitor the continuing education needs of their members and recommend action to our Board of Directors where appropriate. Further, our executive officers are responsible for periodically providing materials or briefing sessions for continuing directors to assist them in discharging their duties. Our Board of Directors also receives periodic briefings and education on core concepts and trends that impact our businesses.

| 2025 Proxy Statement |     | 18 |

TABLE OF CONTENTS

The following table sets forth (i) the four standing committees of our Board of Directors, (ii) the current members of each committee and (iii) the number of meetings held by each committee in fiscal year 2024:

| Name of Director                    |     |        Audit |     | Compensation |     |      Corporate 
 Governance and 
     Nominating |     | Science and 
  Technology |
| William Ericson                     |     |              |     |    X (chair) |     |              X |     |             |
| Randy Livingston                    |     | X (chair)(1) |     |              |     |              X |     |             |
| John F. Milligan, Ph.D.             |     |            X |     |            X |     |                |     |             |
| Marshall Mohr                       |     | X (chair)(2) |     |            X |     |                |     |             |
| Kathy Ordoñez                       |     |              |     |            X |     |                |     |   X (chair) |
| Lucy Shapiro, Ph.D.                 |     |              |     |              |     |      X (chair) |     |           X |
| Christopher M. Smith                |     |              |     |              |     |                |     |        X(3) |
| Hannah A. Valantine, M.D.           |     |              |     |              |     |              X |     |           X |
| Number of meetings held during 2024 |     |            7 |     |            9 |     |              4 |     |           4 |

(1) Mr. Livingston stepped down as Chair of our Audit Committee in February 2025.

(2) Mr. Mohr was appointed as Chair of our Audit Committee in February 2025.

(3) Mr. Smith was appointed